What is mucormycosis? Mucormycosis is a rare fungal infection. Check out our infographic to learn more about how it relates to Covid-19, stats across the world and in India, and it's prevalence now!
Sources:
Sugar, A.M. (1992). Mucormycosis. ClinicNarayanan S, Chua JV, Baddley JW. COVID-19 associated Mucormycosis (CAM): risk factors and mechanisms of disease. Clinical Infectious Disease. 2021. doi: 10.1093/cid/ciab726.
Narayanan, S., Chua, J.V., & Baddley, J.W. (2021). COVID-19 associated Mucormycosis (CAM): risk factors and mechanisms of disease. Clinical Infectious Disease. doi: 10.1093/cid/ciab726.
Muthu, V., Rudramurthy, S.M., Chakrabarti, A. et al. Epidemiology and Pathophysiology of COVID-19-Associated Mucormycosis: India Versus the Rest of the World. Mycopathologia. doi: 10.007/s11046-021-00584-8
Richardson M. (2009). The ecology of the Zygomycetes and its impact on environmental exposure. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 15 Suppl 5, 2–9. doi: 10.1111/j.1469-0691.2009.02972.x
Mucormycosis. (2021). CDC. Retrieved from https://www.cdc.gov/fungal/diseases/mucormycosis/index.html
Sreenivas, S. (2021). Mucormycosis: What to know. WebMD. Retrieved from https://www.webmd.com/lung/mucormycosis-black-fungus-infection
Pushparaj, K., Kuchi Bhotla, H., Arumugam, V. A., Pappusamy, M., Easwaran, M., Liu, W. C., Issara, U., Rengasamy, K., Meyyazhagan, A., & Balasubramanian, B. (2022). Mucormycosis (black fungus) ensuing COVID-19 and comorbidity meets - Magnifying global pandemic grieve and catastrophe begins. The Science of the total environment, 805, 150355. doi: 10.1016/j.scitotenv.2021.150355
Wallen, J. & Townsley, S. (2021). Inside India’s ‘black fungus’ wards: Delta variant linked to hundreds of deaths from mucormycosis. The Telegraph. Retrieved from https://www.telegraph.co.uk/global-health/science-and-disease/indias-black-fungus-wards/
Mucormycosis: India records more than 4,300 'black fungus' deaths. (2021). BBC. Retrieved from https://www.bbc.com/news/world-asia-india-57897682
Raut, A. & Huy, N.T. (2021). Rising incidence of mucormycosis in patients with COVID-19: another challenge for India amidst the second wave?. The Lancet, 9(8): E77. doi: 10.1016/S2213-2600(21)00265-4.
Skiada, A., Lass-Floerl, C., Klimko, N., Ibrahim, A., Roilides, E., & Petrikkos, G. (2018). Challenges in the diagnosis and treatment of mucormycosis. Medical mycology, 56(suppl_1), 93–101. doi: 10.1093/mmy/myx101
Treatment for mucormycosis. (2021). CDC. Retrieved from https://www.cdc.gov/fungal/diseases/mucormycosis/treatment.html